Monitoring for Human Papillomavirus Vaccine Impact Among Gay, Bisexual, and Other Men Who Have Sex With Men—United States, 2012–2014
Author(s) -
Elissa Meites,
Pamina M. Gorbach,
Beau Gratzer,
Gitika Panicker,
Martin Steinau,
Tom Collins,
Adam Parrish,
Cody Randel,
Mark R McGrath,
Steven Carrasco,
J.G. Moore,
Akbar Zaidi,
Jim Braxton,
Peter R. Kerndt,
Elizabeth R. Unger,
Richard A. Crosby,
Lauri E. Markowitz
Publication year - 2016
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiw232
Subject(s) - human papillomavirus , human papillomavirus vaccine , men who have sex with men , homosexuality , virology , medicine , male homosexuality , demography , human immunodeficiency virus (hiv) , gender studies , cervical cancer , sociology , syphilis , cancer , gardasil
Gay, bisexual, and other men who have sex with men (MSM) are at high risk for human papillomavirus (HPV) infection; vaccination is recommended for US males, including MSM through age 26 years. We assessed evidence of HPV among vaccine-eligible MSM and transgender women to monitor vaccine impact.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom